Vito Guagnano

This inventor holds 32 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 23 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Novartis Ag, Irm LLC. Active years: 2005-2018.

USPTO Granted Patents = 32 (Patent Applications = 18)

% Patents Active = 43.8

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 23 (Patent Applications = 24)

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 197(Granted Patents)

Location History:

Lecce, IT (2017)
Basel, CH (2005 - 2018)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2005-2018

Loading Chart...

Areas of Expertise:

FGFR Inhibitor

Pyrazolo-pyrrolidine Derivatives

P53/MDM2 Interaction

BET Inhibitors

Protein Tyrosine Kinase Inhibitors

Pyrrolidine Derivatives

Quinoxaline Carboxamide

Pyrimidinyl Aryl Urea

Thiazole Derivatives

Diarylamine Compounds

Cyclohexyl Isoquinolinone

Substituted Purinone

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10028955 - FGFR inhibitor for use in the treatment of hypophosphatemic disorders (2018-07-24),

2. 9890166 - Imidazopyrrolidine derivatives and their use in the treatment of disease (2018-02-13),

3. 9714249 - Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease (2017-07-25),

4. 9624247 - Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease (2017-04-18),

5. 9556180 - Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction (2017-01-31),

6. 9550796 - Pyrrolopyrrolone derivatives and their use as BET inhibitors (2017-01-24),

7. 9403827 - Substituted purinone compounds (2016-08-02),

8. 9365576 - Pyrrolopyrrolidinone compounds (2016-06-14),

9. 8975417 - Pyrazolopyrrolidine derivatives and their use in the treatment of disease (2015-03-10),

10. 8969341 - Pyrazolopyrrolidine compounds (2015-03-03),

11. 8940771 - Organic compounds (2015-01-27),

12. 8859586 - Cyclohexyl isoquinolinone compounds (2014-10-14),

13. 8815926 - Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases (2014-08-26),

14. 8815901 - Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors (2014-08-26),

15. 8759517 - Pyrirnidinyl aryl urea derivatives being FGF inhibitors (2014-06-24),

Title: Inventor Vito Guagnano

Introduction: Vito Guagnano is a renowned inventor based in Basel, Switzerland, known for his groundbreaking contributions to various fields.

Latest Patents: Vito Guagnano holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the innovation industry, Vito Guagnano has successfully brought numerous inventions from concept to market, revolutionizing the way we approach modern challenges.

Collaborations: Throughout his career, Vito Guagnano has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Vito Guagnano's passion for pushing the boundaries of technology and his relentless pursuit of excellence continue to inspire the next generation of inventors and innovators.